Overall survival impact of BEACOPP versus ABVD in advanced hodgkin lymphoma: a pooled analysis of 4 randomized trials

M. Andre (1) , C Fortpied (2) , S. Viviani (3) , M. Bellei (4) , P. Carde (5) , M. Hutchings (6) , A. Gianni (7) , P. Brice (8) , O Casasnovas, (9, 10) , P. Gobbi , P.L. Zinzani , J. Dupuis, , E. Lannitto , A. Rambaldi , J. Briere , A. Perrot , M. Heczko (11) , P. Valagussa , J. Douxfils (12) , C Joubert , M. Federico , N. Mounier (13)

1 CHU UCL Namur
2 EORTC - European Organisation for Research and Treatment of Cancer [Bruxelles]
3 IRCCS - Istituto di Ricovero e Cura a Carattere Scientifico
4 UNIMORE - Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia
5 IGR - Institut Gustave Roussy
6 Rigshospitalet [Copenhagen]
7 IRCCS Istituto Nazionale dei Tumori [Milano]
8 Service d'hématologie greffe [Saint-Louis]
9 Service d'Hématologie Clinique (CHU de Dijon)
10 LNC - Lipides - Nutrition - Cancer (U866)
11 Service d'Hématologie [CHRU Besançon]
12 Research Unit in Environmental and Evolutionary Biology (URBE), Rue de Bruxelles 61
13 CHU - Hôpital Archet 2 [Nice]

Mots clés: BEACOPP; ABVD; Survival impact; Hodgkin lymphoma

Mots clés: Chimiothérapie

Domaines: Hématologie

M. Andre, C Fortpied, S. Viviani, M. Bellei, P. Carde, et al.. Overall survival impact of BEACOPP versus ABVD in advanced hodgkin lymphoma: a pooled analysis of 4 randomized trials . 10th International Symposium on Hodgkin Lymphoma, Oct 2016, Cologne, Germany. pp.19 (T002). ⟨hal-01502859⟩